Prestige Consumer Healthcare - PBH Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PBH shares.
View PBH analyst ratings or view top-rated stocks.

4 brokers have issued 12-month target prices for Prestige Consumer Healthcare's shares. Their PBH stock forecasts range from $63.00 to $126.00. On average, they expect the company's share price to reach $80.50 in the next year. This suggests a possible upside of 37.0% from the stock's current price.
View analysts price targets for PBH or view top-rated stocks among Wall Street analysts.

Prestige Consumer Healthcare's stock was trading at $60.65 at the beginning of the year. Since then, PBH stock has decreased by 3.1% and is now trading at $58.78.
View the best growth stocks for 2022 here.

Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our PBH earnings forecast.

Prestige Consumer Healthcare Inc. (NYSE:PBH) released its quarterly earnings data on Thursday, November, 4th. The company reported $1.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.99 by $0.03. The firm earned $276.23 million during the quarter, compared to the consensus estimate of $261.23 million. Prestige Consumer Healthcare had a net margin of 18.53% and a trailing twelve-month return on equity of 13.27%. The firm's quarterly revenue was up 16.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.78 earnings per share.

Prestige Consumer Healthcare updated its FY 2023 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of $4.18-$4.23 for the period. The company issued revenue guidance of $1.12 billion-$1.13 billion, compared to the consensus revenue estimate of $1.12 billion.

8 employees have rated Prestige Consumer Healthcare Chief Executive Officer Ronald M. Lombardi on Glassdoor.com. Ronald M. Lombardi has an approval rating of 61% among the company's employees. This puts Ronald M. Lombardi in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), AT&T (T), Intel (INTC), ONEOK (OKE), Wells Fargo & Company (WFC), International Business Machines (IBM), Micron Technology (MU) and Teva Pharmaceutical Industries (TEVA).

Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH."

Prestige Consumer Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (2.01%), Ophir Asset Management Pty Ltd (1.45%), Leeward Investments LLC MA (1.11%), Jennison Associates LLC (0.90%), North Star Asset Management Inc. (0.49%) and Assenagon Asset Management S.A. (0.42%). Insiders that own company stock include Mary Beth Fritz, Paton Brett and Ronald M Lombardi.
View institutional ownership trends.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PBH stock can currently be purchased for approximately $58.78.

Prestige Consumer Healthcare (NYSE:PBH) has a market capitalization of $2.93 billion and generates $1.09 billion in revenue each year. The company earns $205.38 million in net income (profit) each year or $3.99 on an earnings per share basis.

Prestige Consumer Healthcare employs 505 workers across the globe.

Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The official website for the company is www.prestigebrands.com. The company can be reached via phone at (914) 524-6800, via email at irinquiries@prestigebrands.com, or via fax at 302-674-5266.